Sign in

CIK 0001894562 · <br>Emerging growth company

Prime Medicine, Inc.

Sign in to watch
Ticker
PRME
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-465-0013
Business address
60 FIRST ST., CAMBRIDGE, MA, 02141
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. PRE 14A Proxy Proxy Statement (Preliminary)
  4. 4 Derivatives Options or other derivatives
  5. S-8 Other Securities Offered to Employees in Benefit Plans
  6. 10-K Report Annual Report
  7. 8-K Event Results of operations
  8. 3 Insider Initial Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. SC 13D Stake Beneficial Ownership Report
  17. 4 Open-market buy Director bought 3,200,000 shares at $6.25 ($20,000,000)
  18. 4 Open-market buy 10% owner bought 3,200,000 shares at $6.25 ($20,000,000)
  19. 4 Open-market buy 10% owner bought 3,200,000 shares at $6.25 ($20,000,000)
  20. 8-K Event Material agreement

Page 8 of 16 · 302 filings